Healthcare

Investment Banking

Avendus’s Healthcare practice leverages deep domain knowledge of pharma industry, healthcare providers and services, significant transaction and operating experience to provide strategic and corporate finance advice to a wide range of clients including growing businesses, large corporate houses and private equity funds. The group’s philosophy on every transaction revolves around senior team attention, hands-on approach and independent advice delivering best-in-class solutions to clients.

Sub-Sectors in Focus

Our mergers and acquisitions (M&A) advisory and private equity (PE) syndication services are recognized as amongst the best in these chosen sub-sectors.

  • Pharmaceuticals - generics/specialty generics, specialty pharmaceuticals, API / CDMO / CRO
  • Healthcare delivery - hospitals, diagnostics, single specialty
  • Medical technology - lifesciences, medical devices, consumables

Led By

Chintan Kothari

Executive Director and Head, Healthcare, Avendus Capital

Chintan Kothari leads the Healthcare vertical for Avendus's investment banking business and is based in Mumbai.

He has an overall 15 years of experience in investment banking where he led healthcare and consumer vertical for Citigroup and prior to that for Rothschild India. Chintan has extensive transaction experience aggregating over USD 10 billion across pharmaceuticals (generics, injectables, branded generics, API and animal health) and healthcare sub-sectors (hospitals, diagnostics and single specialty). This covers a broad spectrum of transactions including both private and public markets. He has advised several large corporates including Pfizer, Sun Pharma, Lupin, Hindustan Unilever, United Spirits, Apollo Hospitals, Fortis, Dr. Lal Pathlabs, Metropolis as well as multiple mid-market family-owned businesses and several global private equity (PE) funds.

Chintan holds an MBA degree from Case Western Reserve University, USA and a Bachelor of Commerce degree from Sydenham College, Mumbai. He is a CFA charter holder.

Transactions

Jan 2020

Value : USD 50 million

Avendus Capital advises Slayback Pharma LLC on its fundraise
Nov 2019

Value : USD 45 million

Avendus Capital advises NephroPlus and its shareholders on an investment from Investcorp
Dec 2018

Value : USD 1 billion

Avendus is advising Radiant Life Care and KKR on their acquisition of a majority stake in Max Healthcare via a merger
Investment Banking
January 2020

Developments in China aiding Indian Specialty Chemicals Industry

One of the most prominent trends in the global specialty chemicals industry over the last two decades has been the emergence of China as a key supplier in the specialty chemicals space.

Read Time: 6 minutes
Investment Banking
January 2019

How India's services sector is a perfect springboard for automation

Voice recognition software monitors quality of interaction between humans and the external world and has the ability to escalate matters and intervene in real time. Gone are the days where supervisors walked the aisles to troubleshoot.

Read Time: 4 minutes
Investment Banking
July 2019

The value in venture capital

India is going through one of its strongest funding cycles where founders are looking for more than just capital.

Read Time: 6 minutes
Investment Banking
December 2018

How can the auto-component industry survive the new emission norms challenge?

The Indian automotive industry is quickly gearing up for a major technology transformation owing to escalating environmental issues.

Read Time: 4 minutes
Investment Banking
June 2019

Investing in distress – A gold mine or land mine?

We are witnessing a once in a lifetime fire-sale of assets in India and what makes it exciting is that certain strategic assets can be acquired at a deep discount to its replacement value. Assets that have limited operational issues and are only financial distressed can make for a good acquisition.

Read Time: 6 minutes
Investment Banking
November 2018

The landscape for larger, big-ticket M&A transactions in India

M&A transactions in India crossed USD 100 billion in 2018, the highest in last decade. What are the factors driving the large M&A deals?

Read Time: 7 minutes
Investment Banking
January 2019

Five trends that could fuel M&A activity in India

Let us try to put a perspective on the corporate trends that have evolved in our country spanning three generations of entrepreneurs since independence. In the post-independence era, the first-generation entrepreneurs in India seized the opportunity to build, whichever way they could.

Read Time: 6 minutes
Investment Banking
March 2019

AWS Cloud Services: Adding thunder to cloud computing industry

Technology industry is growing faster than global GDP with tech firms leading the list of most highly-valued companies in financial markets across the world. Cloud computing is one of the secular macroeconomic trends driving this USD 3.8 trillion industry.

Read Time: 4 minutes

Reports

Enterprise Technology & Services

Industrials

Get in touch

Connect with us on healthcare@avendus.com and we’ll get in touch with you.